Home/Omios Biologics/Bruno Larida, MSc, MBA
BL

Bruno Larida, MSc, MBA

Chief Business Officer

Omios Biologics

Therapeutic Areas

Omios Biologics Pipeline

DrugIndicationPhase
Oncolytic Virus therapySolid Tumors (e.g., Breast, Liver, Colon)Pre-clinical
Vaccine platformCancer and Infectious DiseasesPre-clinical
Gene Delivery platformSolid TumorsPre-clinical